#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14830	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2263	651.9	0	.	n	.	0	C451T	SNP	451	451	C	675	675	T	866	T,C	412,403	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14830	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2263	651.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1408	1408	C	887	C,G	835,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14830	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2263	651.9	0	HET	.	.	.	C207T	.	207	207	C	431	431	C	851	C,T	641,160	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26910	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3659	733.6	0	.	n	.	0	T695C	SNP	695	695	T	1015	1015	C	810	C,T,G	753,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26910	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3659	733.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2291	2291	C	899	C	823	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26910	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3659	733.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2365	2365	A	832	A	776	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26910	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3659	733.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	2917	2917	C	797	C,T	735,2	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26910	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3659	733.6	0	HET	.	.	.	A1638G	.	1638	1638	A	1958	1958	A	945	A,G	491,397	.	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	1940	folP	855	855	100.0	folP.l6.c30.ctg.1	1514	127.5	1	SNP	p	R229S	1	.	.	685	687	AGC	1080	1082	AGC	221;220;219	A;G;C	201;203;200	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5522	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3259	168.6	1	SNP	p	S91F	1	.	.	271	273	TTC	481	483	TTC	210;209;209	T;T,C;C	198;194,1;197	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5522	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3259	168.6	1	SNP	p	G95N	0	.	.	283	285	GGC	493	495	GGC	206;209;206	G;G,A;C	194;192,1;191	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5522	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3259	168.6	1	SNP	p	D95G	1	.	.	283	285	GGC	493	495	GGC	206;209;206	G;G,A;C	194;192,1;191	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	1702	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1354	125.1	1	SNP	p	G45D	0	.	.	133	135	GGC	497	499	GGC	200;196;196	G;G;C	185;182;184	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	866	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	996	86.2	0	.	n	.	0	A197.	DEL	197	197	A	536	536	A	208	A	187	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5572	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2734	201.7	1	SNP	p	D86N	0	.	.	256	258	GAC	468	470	GAC	221;221;218	G;A;C	204;202;203	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5572	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2734	201.7	1	SNP	p	R87W	0	.	.	259	261	CGT	471	473	CGT	218;214;214	C;G;T	205;204;199	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5572	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2734	201.7	1	SNP	p	R87I	0	.	.	259	261	CGT	471	473	CGT	218;214;214	C;G;T	205;204;199	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5572	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2734	201.7	1	SNP	p	S87R	1	.	.	259	261	CGT	471	473	CGT	218;214;214	C;G;T	205;204;199	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5572	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2734	201.7	1	SNP	p	S88P	0	.	.	262	264	TCC	474	476	TCC	214;215;219	T;C;C	204;202;204	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4104	parE	1986	1986	100.0	parE.l15.c17.ctg.1	2576	158.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1561	1563	GGC	227;226;228	G;G;C	204;202;207	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3936	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2246	173.9	1	SNP	p	A311V	0	.	.	931	933	GCC	1149	1151	GCC	207;209;211	G;C,A;C,T	195;195,1;197,1	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3936	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2246	173.9	1	SNP	p	I312M	1	.	.	934	936	ATG	1152	1154	ATG	209;207;203	A;T;G	198;197;192	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3936	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2246	173.9	1	SNP	p	V316T	1	.	.	946	948	ACC	1164	1166	ACC	205;204;205	A;C;C	192;192;191	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3936	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2246	173.9	1	SNP	p	T316P	0	.	.	946	948	ACC	1164	1166	ACC	205;204;205	A;C;C	192;192;191	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3936	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2246	173.9	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1665	1667	ACC	219;217;218	A;C;C	192;200;199	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3936	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2246	173.9	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1719	1721	GCG	210;209;207	G;C;G	196;196;196	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3936	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2246	173.9	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1719	1721	GCG	210;209;207	G;C;G	196;196;196	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3936	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2246	173.9	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1842	1844	GGT	181;180;179	G;G;T	159;155;155	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3936	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2246	173.9	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1851	1853	AGC	170;169;169	A;G;C	150;149;149	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3936	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2246	173.9	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1869	1871	CCG	151;156;153	C,G;C;G	120,2;126;122	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5862	ponA	2397	2397	100.0	ponA.l6.c4.ctg.1	3060	191.1	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1623	1625	CCG	198;197;198	C;C;G	175;184;178	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2528	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1836	137.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	614	614	C	178	C	164	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2774	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1619	170.8	1	SNP	p	G120K	1	.	.	358	360	AAG	690	692	AAG	210;209;215	A;A;G	195;195;196	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2774	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1619	170.8	1	SNP	p	A121N	1	.	.	361	363	AAC	693	695	AAC	214;213;215	A;A;C	198;197;198	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2774	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1619	170.8	1	SNP	p	N121D	0	.	.	361	363	AAC	693	695	AAC	214;213;215	A;A;C	198;197;198	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10438	rpoB	4179	4179	99.98	rpoB.l15.c30.ctg.1	4745	219.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1126	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1088	103.1	1	SNP	p	V57M	1	.	.	169	171	ATG	569	571	ATG	231;232;231	A;T;G,C	216;215;214,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
